MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Cyllene Therapeutics’ experimental gene therapy EG110A has received US FDA [...]

The FDA has cleared Sapience Therapeutics to begin clinical development [...]

Karyopharm Therapeutics has submitted an application to the FDA seeking [...]

The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

Sagimet Biosciences is preparing to begin screening patients for its [...]

Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

The FDA has granted De Novo marketing authorisation to Avulux, [...]